Kronos Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Kronos Bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 5.91 million shares as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2025-03-18
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 5.91M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.95K shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.39M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.63M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2024-12-31 | 5.91M shares 10-K · filed 2025-03-18 |
| 2023-12-31 | 4.95K shares 10-K · filed 2024-03-21 |
| 2022-12-31 | 3.39M shares 10-K · filed 2023-03-15 |
| 2021-12-31 | 1.63M shares 10-K · filed 2022-02-24 |
| 2020-12-31 | 297.61K shares 10-K · filed 2021-03-23 |
| 2020-09-30 | 69.91K shares 10-Q · filed 2020-11-18 |